Phorum

Supply Partner

BioPhorum’s Maturity Assessment Tool gains momentum

Supplier relationship management is one of the most crucial aspects of biopharmaceutical manufacturing and affects everything from lead times and trust to dialogue and inventory management.

It has been one of the top priorities for BioPhorum and its collaborative work has seen member companies improve their supply chain communications and processes. For example, a recent BioPhorum article highlighted the importance of enhancing the relationship between suppliers and manufacturers.

 

 

It can also be seen in the creation of a Best Practice Guide and Maturity Assessment Tool, which helps members identify improvements and solutions for supply chain issues, and ultimately support the creation of excellence in commercial biological drug supply chains.

Industry use

Since its launch, suppliers and manufacturers have used the tool and seen improved supply chain transparency and performance. Case studies from Merck, AdvantaPure® and GE (Healthcare) have already been collated and will be made available to members.

From a supplier perspective, Dan Tropea, Director of Supply Chain at AdvantaPure®, said “Collaboration across the supply chain not only guarantees optimal service levels but minimizes the inventory levels and expenses associated with unplanned production and delivery. Our end customer is a patient who relies on the industry to perform to its fullest potential; supply chain collaboration is a simple step for the industry to take.”

In the biomanufacturing community, Christian Menzel, Head of Manufacturing Science and Technology at Merck, said “We surveyed our global manufacturing network at the leadership team level. The aim was to achieve a step-change in the performance of the inbound supply chain, based on data-driven processes and decision making. The Maturity Assessment Tool gave us confidence that we could develop a baseline of the current state and identify the key places to focus our improvement efforts.”

Case study: AdvantaPure®– Improving customers’ on-time delivery (OTD) at AdvantaPure®

 

The context

AdvantaPure® was facing challenges as its internal goal of OTD (for 95% of sales lines) was not on target.

The story

Using the BioPhorum Maturity Assessment Tool, a full review of OTD data found that the management of extreme demand deviations was the leading cause of the missed OTD metric. Customers of specific items were targeted to improve forecasting collaboration and enhance manufacturing schedules and inventory levels.

The outcomes

Only 30% of the targeted customers regularly participated in the forecast collaboration program, but their OTD service level consistently exceeded 95%. The other 70% did not have such a consistently high service level. Generally, forecasting collaboration lacked strong communication at the end of the supply chain.

The lessons learned

Unless there is a costly increase in overall inventory levels, improvements in OTD can only happen if all supply chain parties collaborate. The cost of collaboration is relatively inexpensive compared to the cost of production, increasing inventories and drug outages.

Next steps

As use of the tool continues to build across the industry, BioPhorum will maintain a collection of information and best practice that will be continually updated and shared. The Forecast and Demand Planning team is also being reformed to address the industry challenges associated with increased growth and supply chain pressures. The team will be developing planning and delivery targets over the coming weeks.

For more information, contact Bob Brooks at bob@biophorum.com

 

 

Contact address

BioPhorum
The Gridiron Building
One Pancras Square
London
N1C 4AG

Newsletter subscribe

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.



© 2019 Biophorum Operations Group · All Rights Reserved

Registered Address: 5 Westbrook Court · 2 Sharrow Vale Road · Sheffield · S11 8YZ

Company Number 06794795 · VAT Number GB298617544

Driving progress in Cell & Gene Therapy

Now with 19 member companies and 183 subject matter experts, the BioPhorum Cell & Gene Therapy (C>) Phorum has made great strides since its formation[...]

Read More
Cell and Gene Therapy Phorum accelerates progress

The BioPhorum Cell & Gene Therapy Phorum has made significant progress since its creation in 2018 – from building networks and sharing knowledge to endorsing[...]

Read More
2018 highlights

BioPhorum’s mission has always been to make the journey for tackling industry challenges better, faster and cheaper for members. By helping you to work on[...]

Read More
Industry bioassay approach helps to shape the future

In 2018, members of the Development Group Bioassay workstream came together to write a best practices paper on bioassay development. We are delighted to announce[...]

Read More
Sharing ideas on forced degradation

“Forced degradation studies are an important part of the drug lifecycle process as they can inform many aspects of drug development,” said Jennifer Halley, Principal[...]

Read More
The BioPhorum and USP collaborative journey to new standards

BioPhorum and United States Pharmacopeia (USP) share a common direction – to accelerate biopharma innovation, quality and progress through collaboration.

Read More
Proactive prioritization: a new tool for assessing raw material risk

The Raw Material Risk Management workstream has launched a new, raw material risk assessment tool aimed at helping industry identify and prioritize around the challenging[...]

Read More
How well can you handle SUS changes?  Take our surveys and see

BioPhorum delivery of value from the disposables five-year plan - supplier change notifications for single-use systems

Read More
Decision tree to support alignment of risk assessment for changes to single-use biomanufacturing systems

The BioPhorum single use change notification team has been working on developing and standardizing best practice for single use change notification since 2015.  The challenges[...]

Read More
PUPSIT – An update on BioPhorum/PDA work to develop a risk-based position
Read More
Driving the evolution of secondary packaging

How do we transition from large-batch manufacture to small-batch, high-value packaging runs?

Read More
Hi-tech ambitions for Fill Finish

The Fill Finish Phorum has recently embarked on a series of exciting and ambitious initiatives, exploring new technologies and processes to enhance the efficiency and[...]

Read More
Logistics collaboration hub: An opportunity for significant time and cost savings

Most biopharmaceutical manufacturers use a network of logistics service providers (LSPs) to deliver warehousing, transport and distribution services, and they are usually linked using customized,[...]

Read More
The ‘how to’ guide to implementing Agile in GxP

The publication of the Guidance on the use of Agile in a GxP Environment document in 2017 was well received.It described how the use of[...]

Read More
How smart is your maintenance?

Faster. Cheaper. Smarter. All companies are under pressure to achieve more with less, not least with their maintenance programs. But while ‘faster’ and ‘cheaper’ maintenance[...]

Read More
BioPhorum’s Maturity Assessment Tool gains momentum
Read More
Supply chain, forecasting and demand planning solutions gain momentum

The relationship between suppliers and manufacturers is one of the most crucial in biopharmaceutical manufacturing. This is especially the case when forecasting and supply planning.[...]

Read More
2018 highlights

BioPhorum’s mission has always been to make the journey for tackling industry challenges better, faster and cheaper for members. By helping you to work on[...]

Read More
Removing the roadblocks to continuous biomanufacturing

Continuous downstream processing is increasingly seen as a feasible approach for manufacturing biologics. The industry recognises that it offers advantages over batch-based processing by:

Read More
Changing mindsets with a modular approach

Historically, manufacturers have used a ‘waterfall’ approach when designing and building their production facilities, sequentially resolving and specifying all aspects up front and in detail[...]

Read More
How do you bring technology roadmapping to life?

You use it to make change happen and that is exactly what the Phorum’s leaders did after the first edition of the Biomanufacturing Technology Roadmaps[...]

Read More
Slicing years off change implementation

As the first regulatory authority in Latin America to gain full membership of the International Council for Harmonization (ICH), the Brazilian Health Regulatory Agency (Anvisa)[...]

Read More
BioPhorum Regulatory Interaction: helping to open doors

To implement any change in the biopharmaceutical manufacturing industry it is important to engage with and collaborate with the regulators. Set up two years ago,[...]

Read More
Regulatory compliance: what lessons can be learned?

BioPhorum delivery of value from the disposables five-year plan - supplier change notifications for single-use systems

Read More
Navigating the maze of medical technology regulation: a solo voyage or a team effort?

Medical technology is a global business, generating annual revenues of over $400bn. The sector encompasses a broad range of technologies: from in-vitro diagnostics and diagnostic[...]

Read More

IaaS Cloud webinar recording play back
Read More
New BPIT guidance to align cloud services to regulatory requirements
Read More
Data Integrity and Agile Webinars to support industry response to regulators
Read More
How to validate informatics in CPV programs

The BioPhorum Continued Process Verification (CPV) and Informatics team has published a paper to support a risk-based approach for the validation of informatics systems for[...]

Read More
Continued Process Verification delivering real saving in time and money

More than 50 per cent of biopharma products on the market now have Continued Process Verification (CPV) plans in place.  Thanks to the CPV white[...]

Read More
A roadmap for the implementation of continued process verification

This article provides a roadmap draws on the content of the CPV case study to provide a step-by-step guide in a more accessible form.

Read More
How smart is your maintenance?

Faster. Cheaper. Smarter. All companies are under pressure to achieve more with less, not least with their maintenance programs. But while ‘faster’ and ‘cheaper’ maintenance[...]

Read More
Digital plant maturity model webinar replay
Read More
Digital Plant Maturity Model workstream to host webinar
Read More
New guidance available on Forecasting and Demand Planning to streamline supply chain performance
Read More
Host cell proteins poster

This poster presented at the BEBPA Conference, San Francisco builds and consolidates the information currently available in the industry for assessing process risk from Host[...]

Read More
Host cell protein risk assessment, an industry approach

Host cell protein (HCP) constitutes a significant class of process-related impurities in biological drugs.

Read More
BEBPA risk assessment workshop
Read More
PUPSIT – An update on BioPhorum/PDA work to develop a risk-based position
Read More
BioPhorum’s Maturity Assessment Tool gains momentum
Read More
Driving the evolution of secondary packaging

How do we transition from large-batch manufacture to small-batch, high-value packaging runs?

Read More